Benzinga | Nov 17, 2021 07:15AM EST

RBC Capital Maintains Sector Perform on Fresenius Medical Care, Lowers Price Target to $35

RBC Capital analyst Frank Morgan maintains Fresenius Medical Care (NYSE:FMS) with a Sector Perform and lowers the price target from $42 to $35.